MENTIONS — KPG

Be the change you want to see in the world

AltiBio is currently advancing several promising projects targeting an undisclosed rare disease

KPG Capital & CoMay 18, 2025

At Alta Partners, trust is the cornerstone of all interactions, both internally and with external partners

KPG Capital & CoMay 18, 2025

Alnylam has been a trailblazer in the development of RNAi therapeutics

KPG Capital & CoMay 18, 2025

At the heart of Alloy Therapeutics is a mission to drive innovation in the biotechnology field

KPG Capital & CoMay 18, 2025

Allosteric modulation involves influencing a protein’s function by binding to a site

KPG Capital & CoMay 18, 2025

Alkeus’ lead molecule, gildeuretinol (ALK−001), has shown tremendous promise in addressing this critical issue

KPG Capital & CoMay 18, 2025

At Alkermes, environmental responsibility is a core value that drives the company’s operations

KPG Capital & CoMay 18, 2025

At the heart of Alexza’s product lineup is the Staccato® OBT™ system, an innovative drug delivery method

KPG Capital & CoMay 18, 2025

Aleta Biotherapeutics’ CTEs address this challenge by enhancing the expression of CAR T

KPG Capital & CoMay 18, 2025

Alcami provides a broad range of services tailored to meet the unique needs of its clients

KPG Capital & CoMay 18, 2025

At the heart of Akttyva Therapeutics’ innovation is their proprietary AI−assisted platform, AIDE−360

KPG Capital & CoMay 18, 2025

Sensorineural hearing loss, which affects millions of individuals world wide, is caused by damage to the inner ear

KPG Capital & CoMay 18, 2025

Akcea’s mission is to transform the treatment landscape for kidney disease by developing therapeutics

KPG Capital & CoMay 18, 2025

Aisling Capital seeks out companies that are developing breakthrough technologies

KPG Capital & CoMay 18, 2025

Airgas, Inc., a subsidiary of Air Liquide, is a leading U.S. supplier of industrial, medical, and specialty gases

KPG Capital & CoMay 18, 2025

Agios prioritizes the growth and development of its employees by fostering a collaborative

KPG Capital & CoMay 18, 2025

Agenus recently presented compelling survival data for the botensilimab and balstilimab combination

KPG Capital & CoMay 18, 2025

Agastiya Biotech is not just another biotech or pharma company

KPG Capital & CoMay 18, 2025

Aer Therapeutics is committed to addressing the unmet needs of patients suffering from chronic respiratory conditions

KPG Capital & CoMay 18, 2025

ADvantage Therapeutics is committed to addressing the urgent need for effective treatments for Alzheimer’s disease

KPG Capital & CoMay 18, 2025